Affiliation:
1. Russian Scientific Center for Roentgenoradiology, Moscow, Russia
Abstract
Progression assessment enables implementation of the colorectal cancer (CRC) tertiary prevention measures aimed at early detection and timely treatment of metastatic cancer. The study was aimed to develop a model of CRC progression using pathomorphological and molecular genetic characteristics of tumors. Relative expression of mRNAs of 63 genes from various functional groups was determined in the tumor specimens of 223 patients with stage T1–4N0–2M0 CRC. The median follow-up period was 42 months. Binary logistic regression models were constructed, in which likelihood of progression within 36 months after the CRC diagnosis was a target variable. Explanatory variables were as follows: tumor grade, angiolymphatic invasion, ratio of the number of metastatic lymph nodes to the total number of lymph nodes in the surgical specimen, patient’s age and tumor localization, as well as expression levels of genes CCNB1, Ki67, GRB7, IGF1, Il2, Il6, Il8, GATA3. Prediction accuracy of the model using clinical and morphological characteristics was 56.6%. Inclusion of CCNB1, Ki67, GRB7, IGF1, Il2, Il6, Il8, GATA3 expression profiles in the model increased accuracy to 80.6%. Thus, prediction of CRC progression for treatment personalization requires additional parameters beyond information acquired within the framework of conventional morphological TNM classification. The use of molecular markers as predictors significantly increases the CRC progression prediction accuracy. Further research is needed for validation and quality improvement of prognostic models.
Publisher
Pirogov Russian National Research Medical University
Reference20 articles.
1. Kaprin AD, Starinskij VV, Shahzadova AO. Sostojanie onkologicheskoj pomoshhi naseleniju Rossii v 2021 godu. Rossijskij Centr informacionnyh tehnologij i jepidemiologicheskih issledovanij v oblasti onkologii. Moskva, 2022. Russian.
2. Steyerberg EW, Moons KGM, van der Windt DA, et al. Prognosis Research Strategy (PROGRESS) 3: prognostic model research. PLoS medicine. 2013; 10: e1001381.
3. Brenner H, Chen C. The colorectal cancer epidemic: challenges and opportunities for primary, secondary and tertiary prevention. Br J Cancer. 2018; 119 (7): 785–92. DOI: 10.1038/s41416018-0264-x. Epub 2018 Oct 4. PMID: 30287914; PMCID: PMC6189126.
4. Lin XT, Wu QN, Qin S, Fan DJ, Lv MY, Chen X, et al. Identification of an Autophagy-Related Gene Signature for the Prediction of Prognosis in Early-Stage Colorectal Cancer. Front Genet. 2021; 12: 755789. DOI: 10.3389/fgene.2021.755789. PMID: 34899841; PMCID: PMC8657766.
5. Mori K, Toiyama Y, Okugawa Y, Ichikawa T, Nagano Y, Oki S, et. al. Preoperative heat shock protein 47 levels identify colorectal cancer patients with lymph node metastasis and poor prognosis. Oncol Lett. 2020; 20 (6): 333. DOI: 10.3892/ol.2020.12196. Epub 2020 Oct 7. PMID: 33123244; PMCID: PMC7583735.